The proliferation marker thymidine kinase 1 in clinical use
about
Thymidine kinase 1 is a better prognostic marker than Ki-67 for pT1 adenocarcinoma of the lung.Serum thymidine kinase 1 levels predict cancer-free survival following neoadjuvant, surgical and adjuvant treatment of patients with locally advanced breast cancerBreast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarkerSerum thymidine kinase activity: analytical performance, age-related reference ranges and validation in chronic lymphocytic leukemiaSerum thymidine kinase 1 is a reliable maker for the assessment of the risk of developing malignancy: A case report.Dysregulation of mitotic machinery genes precedes genome instability during spontaneous pre-malignant transformation of mouse ovarian surface epithelial cells.Expression and Clinical Significance of Cytokeratin-19 and Thymidine Kinase-1 in Advanced Gastrointestinal Cancer.Thymidine Kinase Type 1 and C-Reactive Protein Concentrations in Dogs with Spontaneously Occurring Cancer.Serum Thymidine Kinase 1, Canine-C-Reactive Protein, Haptoglobin, and Vitamin D Concentrations in Dogs with Immune-Mediated Hemolytic Anemia, Thrombocytopenia, and Polyarthropathy.Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt's lymphoma and acute lymphoblastic leukemia.Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer.Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses.Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker.Serum 8-Oxo-dG as a Predictor of Sensitivity and Outcome of Radiotherapy and Chemotherapy of Upper Gastrointestinal Tumours.Serum thymidine kinase 1 is associated with Gleason score of patients with prostate carcinoma
P2860
Q34167119-F45AA2ED-79ED-4E95-B0E7-B6EEBE7F479EQ34411112-DBF53E8A-7173-4206-A7BF-08AFDD522ACFQ34472094-98A5E726-4E8A-413C-A522-3D02F51E129AQ35118658-C82CFC42-D3F1-43CE-8F69-A514D9141757Q35944455-F9BD5928-9C34-4596-81D6-97CAC99EF2C1Q36179026-D3BC3296-FDCC-45C2-84EA-E887BD94A577Q37254986-F34B0CB2-97A3-467B-9246-5810E0418825Q37384789-5A5814B7-D7B0-4443-A72F-B2F1C0FC7AA8Q41075307-419F6B6C-6C13-4291-A211-E5DC40D7E16CQ41355129-623403BD-691A-4056-9DA8-91F52DAFF726Q41860640-821E6F26-9A8A-4E64-AD25-6F2EFD2126D1Q41919532-2844D29A-1342-48A4-B0E2-63293BBC69F9Q50922678-0851CBEC-F3CE-4E02-B1EA-C17D862B7923Q55410083-E90F7CFA-40DF-4B10-8DE7-CB4A18913F89Q58573232-A1ED00AB-5A04-44F9-B021-498F5FAC7582
P2860
The proliferation marker thymidine kinase 1 in clinical use
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The proliferation marker thymidine kinase 1 in clinical use
@en
The proliferation marker thymidine kinase 1 in clinical use
@nl
type
label
The proliferation marker thymidine kinase 1 in clinical use
@en
The proliferation marker thymidine kinase 1 in clinical use
@nl
prefLabel
The proliferation marker thymidine kinase 1 in clinical use
@en
The proliferation marker thymidine kinase 1 in clinical use
@nl
P2093
P2860
P356
P1476
The proliferation marker thymidine kinase 1 in clinical use
@en
P2093
P2860
P356
10.3892/MCO.2012.19
P577
2012-09-04T00:00:00Z